BRIEF published on 03/05/2025 at 10:13, 1 year 5 months ago EUROPLASMA: Répartition des droits de vote et actions au 28 février 2025 Droits De Vote Capital Social Europlasma Euronext Growth Actions En Circulation
BRIEF published on 03/05/2025 at 10:13, 1 year 5 months ago EUROPLASMA: Distribution of voting rights and shares as of February 28, 2025 Share Capital Voting Rights Europlasma Euronext Growth Shares Outstanding
PRESS RELEASE published on 03/05/2025 at 10:08, 1 year 5 months ago EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 28 février 2025 Europlasma divulgue le nombre total d'actions et de droits de vote au 28 février 2025 conformément à la réglementation financière. Détails ci-dessous Capital Droits De Vote Actions Europlasma Information
BRIEF published on 02/18/2025 at 07:35, 1 year 5 months ago Europlasma : Soutien confirmé pour les Forges de Tarbes Financement Europlasma Defense Export Forges De Tarbes
BRIEF published on 02/18/2025 at 07:35, 1 year 5 months ago Europlasma: Support confirmed for the Forges de Tarbes Funding Europlasma Defense Export Forges Of Tarbes
BRIEF published on 02/18/2025 at 07:35, 1 year 5 months ago EUROPLASMA: Progression du Soutien aux Forges de Tarbes Investissement Europlasma Exportation Forges De Tarbes Industrie Défense
BRIEF published on 02/18/2025 at 07:35, 1 year 5 months ago EUROPLASMA: Progress in Support for the Forges de Tarbes Investment Europlasma Defense Industry Export Forges Of Tarbes
PRESS RELEASE published on 02/18/2025 at 07:30, 1 year 5 months ago EUROPLASMA: Soutien à l’investissement export des Forges de Tarbes confirmé Europlasma confirme le soutien financier aux Forges de Tarbes pour l'export. Montant de 4.1 M€ accordé pour renforcer les capacités industrielles. Soutien de la Direction générale de l'armement Europlasma Soutien Financier Forges De Tarbes Investissement Export Capacités Industrielles
PRESS RELEASE published on 02/18/2025 at 07:30, 1 year 5 months ago EUROPLASMA: Soutien à l’investissement export des Forges de Tarbes confirmé Europlasma confirme le soutien à l'investissement export des Forges de Tarbes avec une deuxième tranche d'avance remboursable de 4,1 M€ pour renforcer les capacités industrielles Europlasma Industrie De La Défense Forges De Tarbes Investissement Export Avance Remboursable
BRIEF published on 02/17/2025 at 07:35, 1 year 5 months ago Europlasma décroche un contrat pour des obus en Tchéquie Contrat Europlasma Dépollution Tchéquie Obus Gros Calibre
Published on 08/10/2026 at 08:00, 2 hours 33 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 33 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 11 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 10:12, 21 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/10/2026 at 10:10, 23 minutes ago Hana Bank Subsidiary GLN Expands QR Payment Network for International Travelers to Korea
Published on 08/10/2026 at 09:50, 43 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 33 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 33 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:22, 1 hour 11 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 1 hour 11 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 33 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 33 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
